Jessica Campbell

With positive Phase 3 data and an FDA review underway, a novel copper IUD aims to double its lifespan while navigating strict new provider safety mandates.

Ørsted’s 200 MW Blackwater Solar project isn’t just about green energy. It’s a masterclass in navigating industrial demand, IRA incentives, and local politics.

While Silicon Valley builds AI for 5G smartphones, blackNgreen is leveraging 1980s telephony to bring LLMs to the 3.4 billion people offline.

As ABZ Innovation unveils a massive new manufacturing hub in Hungary, the real story isn't just agriculture—it's about European technological sovereignty.

The opening of a 50th clinic signals more than growth. It reveals a model using hard data and private equity to scale, raising new questions about access.

Lawyers for Justice, P.C.'s latest senior hire is more than an expansion. It's a calculated move into a hot legal market with a uniquely equipped strategist.

With a new £350M facility, private giant Collinson Group isn't just expanding. It's executing a bold, integrated plan to own the future of travel.

A new 347 MW solar farm breaks ground near Houston, but the real story is the strategic international alliance and corporate demand fueling Texas's future.

Beyond the polish of IFA 2026, Levoit's new smart home tech reveals a deeper strategy by parent VeSync: to build an integrated wellness ecosystem, one quiet device at a time.

Beyond standard PR, Netmarble's intimate player event in Jakarta reveals a calculated strategy to secure Indonesia and build a foundation of trust for RF ONLINE NEXT.

How DeeDee Wright-Ward’s rejection of ‘ambiguous multiculturalism’ built a toy empire and convinced Walmart that cultural authenticity is big business.

HiTHIUM's new EU certification is not just about meeting rules. It's a calculated move to leverage Europe's tough new battery law as a competitive weapon.

A new firm, led by a former pastor, is betting that shared Christian values can revolutionize financial planning. Is this the future of wealth advice?

Quoin Pharmaceuticals scores key regulatory wins for its rare skin disease drugs, offering hope where none existed. But can its cash hold out long enough?

With a cash runway to 2029 and a novel cancer drug nearing key data, NuCana signals quiet confidence in a high-stakes race to treat resistant melanoma.

While many companies chase rapid expansion, Go Mini's is quietly building an empire by empowering its best franchisees. This is a look at their 'quality over speed' playbook.

Construction Resources' new Dallas hub isn't just a showroom. It's a calculated play in The Home Depot's larger strategy to dominate the pro design market.

The new Visual Comfort showroom in Newton is more than a retail space; it's a calculated move into the affluent Boston market, betting big on wellness.

Making the Inc. 5000 once is hard. Four times? Levitate's success shows its 'relationship-first' model is more than a trend—it's a new benchmark.

Japan's ENEOS Holdings is acquiring TPC Group for a reported $1.3B. This isn't just a deal; it's a strategic realignment of the global chemical supply chain.